Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Patient choice in opt-in, active choice, and opt-out HIV screening: randomized clinical trial.

Montoy JC, Dow WH, Kaplan BC.

BMJ. 2016 Jan 19;532:h6895. doi: 10.1136/bmj.h6895.

2.

Genetic testing for Lynch syndrome: family communication and motivation.

Leenen CH, Heijer Md, van der Meer C, Kuipers EJ, van Leerdam ME, Wagner A.

Fam Cancer. 2016 Jan;15(1):63-73. doi: 10.1007/s10689-015-9842-8.

3.

Timing and context: important considerations in the return of genetic results to research participants.

McBride KA, Hallowell N, Tattersall MH, Kirk J, Ballinger ML, Thomas DM, Mitchell G, Young MA.

J Community Genet. 2016 Jan;7(1):11-20. doi: 10.1007/s12687-015-0231-7. Epub 2015 May 26.

4.

Value of Genetic Testing for Hereditary Colorectal Cancer in a Probability-Based US Online Sample.

Knight SJ, Mohamed AF, Marshall DA, Ladabaum U, Phillips KA, Walsh JM.

Med Decis Making. 2015 Jan 14. pii: 0272989X14565820. [Epub ahead of print]

5.

An exploratory study of inactive health information seekers.

Kim S.

Int J Med Inform. 2015 Feb;84(2):119-33. doi: 10.1016/j.ijmedinf.2014.10.003. Epub 2014 Oct 22.

6.

Population-based genetic risk prediction and stratification for ovarian cancer: views from women at high risk.

Rahman B, Meisel SF, Fraser L, Side L, Gessler S, Wardle J, Lanceley A.

Fam Cancer. 2015 Mar;14(1):135-44. doi: 10.1007/s10689-014-9769-5.

7.

Long-term psychosocial and behavioral adjustment in individuals receiving genetic test results in Lynch syndrome.

Esplen MJ, Wong J, Aronson M, Butler K, Rothenmund H, Semotiuk K, Madlensky L, Way C, Dicks E, Green J, Gallinger S.

Clin Genet. 2015 Jun;87(6):525-32. doi: 10.1111/cge.12509. Epub 2014 Oct 28.

8.

Attitudes of non-African American focus group participants toward return of results from exome and whole genome sequencing.

Yu JH, Crouch J, Jamal SM, Bamshad MJ, Tabor HK.

Am J Med Genet A. 2014 Sep;164A(9):2153-60. doi: 10.1002/ajmg.a.36610. Epub 2014 May 20.

9.

Reflex testing for Lynch syndrome: if we build it, will they come? Lessons learned from the uptake of clinical genetics services by individuals with newly diagnosed colorectal cancer (CRC).

Tomiak E, Samson A, Spector N, Mackey M, Gilpin C, Smith E, Jonker D, Allanson J, Asmis T.

Fam Cancer. 2014 Mar;13(1):75-82. doi: 10.1007/s10689-013-9677-0.

10.

Health behaviors in patients and families with hereditary colorectal cancer.

Burton AM, Hovick SR, Peterson SK.

Clin Colon Rectal Surg. 2012 Jun;25(2):111-7. doi: 10.1055/s-0032-1313782.

11.

Genetic risk assessment for women with epithelial ovarian cancer: referral patterns and outcomes in a university gynecologic oncology clinic.

Petzel SV, Vogel RI, Bensend T, Leininger A, Argenta PA, Geller MA.

J Genet Couns. 2013 Oct;22(5):662-73. doi: 10.1007/s10897-013-9598-y. Epub 2013 May 16.

12.

Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts.

Vasen HF, Blanco I, Aktan-Collan K, Gopie JP, Alonso A, Aretz S, Bernstein I, Bertario L, Burn J, Capella G, Colas C, Engel C, Frayling IM, Genuardi M, Heinimann K, Hes FJ, Hodgson SV, Karagiannis JA, Lalloo F, Lindblom A, Mecklin JP, Møller P, Myrhoj T, Nagengast FM, Parc Y, Ponz de Leon M, Renkonen-Sinisalo L, Sampson JR, Stormorken A, Sijmons RH, Tejpar S, Thomas HJ, Rahner N, Wijnen JT, Järvinen HJ, Möslein G; Mallorca group.

Gut. 2013 Jun;62(6):812-23. doi: 10.1136/gutjnl-2012-304356. Epub 2013 Feb 13.

13.

Perceptions about genetic testing for the susceptibility to alcohol dependence and other multifactorial diseases.

Marshall VJ, Kalu N, Kwagyan J, Williams C, Taylor RE, Scott DM.

Genet Test Mol Biomarkers. 2012 Jun;16(6):476-81. doi: 10.1089/gtmb.2011.0069. Epub 2011 Dec 22.

14.

The role of distress in uptake and response to predisposition genetic testing: the BMPR2 experience.

Jones DL, Clayton EW.

Genet Test Mol Biomarkers. 2012 Mar;16(3):203-9. doi: 10.1089/gtmb.2011.0059. Epub 2011 Nov 15.

15.
16.

Development and validation of an instrument to measure the impact of genetic testing on self-concept in Lynch syndrome.

Esplen MJ, Stuckless N, Gallinger S, Aronson M, Rothenmund H, Semotiuk K, Stokes J, Way C, Green J, Butler K, Petersen HV, Wong J.

Clin Genet. 2011 Nov;80(5):415-23. doi: 10.1111/j.1399-0004.2011.01770.x. Epub 2011 Oct 3.

17.

Why is genetic screening for autosomal dominant disorders underused in families? The case of hereditary hemorrhagic telangiectasia.

Bernhardt BA, Zayac C, Pyeritz RE.

Genet Med. 2011 Sep;13(9):812-20. doi: 10.1097/GIM.0b013e31821d2e6d.

18.

Black and White adults' perspectives on the genetics of nicotine addiction susceptibility.

Park ER, Kleimann S, Youatt EJ, Lockhart A, Campbell EG, Levy DE, Halbert CH, Schmieder E, Krishna R, Shields AE.

Addict Behav. 2011 Jul;36(7):769-72. doi: 10.1016/j.addbeh.2011.02.007. Epub 2011 Feb 25.

19.

Colonoscopy use following mutation detection in Lynch syndrome: exploring a role for cancer screening in adaptation.

Hadley DW, Ashida S, Jenkins JF, Calzone KA, Kirsch IR, Koehly LM.

Clin Genet. 2011 Apr;79(4):321-8. doi: 10.1111/j.1399-0004.2010.01622.x. Epub 2011 Jan 19.

20.

Hopefulness predicts resilience after hereditary colorectal cancer genetic testing: a prospective outcome trajectories study.

Ho SM, Ho JW, Bonanno GA, Chu AT, Chan EM.

BMC Cancer. 2010 Jun 11;10:279. doi: 10.1186/1471-2407-10-279.

Items per page

Supplemental Content

Write to the Help Desk